New horizons in pharmaceutical regulation

被引:8
|
作者
Breckenridge, Alasdair [1 ]
Mello, Michelle [2 ]
Psaty, Bruce M. [3 ]
机构
[1] Med & Healthcare Prod Regulatory Agcy, London SW1W 9SZ, England
[2] Harvard Univ, Cambridge, MA 02115 USA
[3] Univ Washington, Med Epidemiol & Hlth Serv, Seattle, WA 98101 USA
关键词
D O I
10.1038/nrd3787
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A life cycle approach to pharmaceutical regulation, in which the benefit–risk balance of new drugs continues to be robustly assessed following market approval, is emerging in both the United States and Europe.
引用
收藏
页码:501 / 502
页数:2
相关论文
共 50 条